PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
28.38%
Revenue growth 1.25-1.5x AR's 20.40%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
46.50%
Gross profit growth at 50-75% of AR's 73.35%. Martin Whitman would question if cost structure or brand is lagging.
202.59%
EBIT growth above 1.5x AR's 114.66%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
202.59%
Operating income growth above 1.5x AR's 114.66%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
125.83%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
125.00%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
125.32%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.20%
Slight or no buybacks while AR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.51%
Reduced diluted shares while AR is at 0.03%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-1.19%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
86.32%
OCF growth above 1.5x AR's 41.72%. David Dodd would confirm a clear edge in underlying cash generation.
401.67%
FCF growth above 1.5x AR's 78.49%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-90.79%
Negative 10Y revenue/share CAGR while AR stands at 1038.23%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-29.92%
Negative 5Y CAGR while AR stands at 243.08%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-15.32%
Negative 3Y CAGR while AR stands at 147.44%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-77.27%
Negative 10Y OCF/share CAGR while AR stands at 440.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-26.83%
Negative 5Y OCF/share CAGR while AR is at 149.28%. Joel Greenblatt would question the firm’s operational model or cost structure.
71.99%
3Y OCF/share CAGR 1.25-1.5x AR's 50.59%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-99.14%
Negative 10Y net income/share CAGR while AR is at 0.18%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-83.96%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
102.78%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
-78.42%
Negative equity/share CAGR over 10 years while AR stands at 288.60%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-7.26%
Negative 5Y equity/share growth while AR is at 247.82%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-14.91%
Negative 3Y equity/share growth while AR is at 20.43%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-96.32%
Cut dividends over 10 years while AR stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-89.89%
Negative 5Y dividend/share CAGR while AR stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-67.57%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-16.54%
Firm’s AR is declining while AR shows 12.25%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
1.26%
Asset growth above 1.5x AR's 0.71%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.23%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.03%
We’re deleveraging while AR stands at 3.76%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-9.70%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.